Currently, the clinical diagnosis of schizophrenia relies solely on clinical interview, and likely comprises heterogeneous biological subsets. A recent study in… Read more »
Carsten Korth, MD PhD is a trained psychiatrist gone molecular research from the University of Düsseldorf, Germany. He was trained, between others, at the Max Planck Institute for Psychiatry, Germany, and the University of California San Francisco. He has pioneered the notion that aberrant proteostasis and protein misfolding could be key to biologically define subsets of schizophrenia.
Latest posts by Carsten Korth (see all)
- Is schizophrenia accurately and objectively diagnosed? - 18th July 2019